Prosthetic Reconstruction, Rehabilitation & Surgical Planning —
Training activity: 30

Details

Attend a morbidity and mortality (M&M) clinical governance meeting

Bring lessons back into the laboratory regarding a specific case. Make recommendations about practice within the department

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What is the purpose of an M&M meeting? How can lessons learned from specific cases
• What will you learn about the clinical governance processes within the department?
• How are adverse events or complications discussed and analysed in an M&M setting?
• How can you effectively translate lessons learned into actionable recommendations for laboratory practice?
• Have you discussed the agenda and focus of the upcoming M&M meeting with your supervisor?
• Have you considered a specific case that might be relevant to laboratory practice?
• How will you take notes and identify key learning points during the meeting?
• How will you formulate recommendations for practice changes based on the discussion?

In action

• Are you ensuring that your recommendations are evidence-based and aimed at improving patient care and laboratory processes?
• While attending the M&M meeting, are you actively listening to the case discussion and identifying factors that contributed to the outcome?
• What specific aspects of the case are relevant to laboratory practice?
• When formulating recommendations, are you focusing on practical and implementable changes that could prevent similar occurrences?
• Are you finding the M&M meeting to be a valuable learning experience?
• Are you encountering any challenges in understanding the clinical context of the case or identifying relevant lessons for the laboratory?
• What immediate insights are you gaining into the importance of clinical governance and interdepartmental communication?
• How does this activity connect to your understanding of quality management and patient safety?
• If the case discussed in the M&M meeting presents complex issues or if you are unsure about the most effective recommendations for laboratory practice, are you considering seeking further information or discussing the case with colleagues before finalising your recommendations?

On action

• Describe the structure and dynamics of the morbidity and mortality (M&M) meeting. What were the key aspects of the specific case discussed? What lessons learned from the case did you identify that are relevant to laboratory practice? What specific recommendations did you formulate for changes in practice within the department?
• What specific skills or knowledge did you develop or improve in understanding clinical governance processes and translating clinical insights into laboratory practice improvements? What did you learn about the importance of learning from adverse events and near misses? Were there any unexpected insights gained during the meeting? What did you learn from these? How does participation in M&M meetings contribute to patient safety and quality improvement?
• What aspects of clinical governance and evidence-based practice improvement will you focus on developing further? How can you apply the knowledge gained to future participation in such meetings and to identify areas for practice improvement in the laboratory? What resources or support might you need to further develop your understanding of clinical governance frameworks?

Beyond action

• Have you revisited your experience of attending an M&M meeting? How has your understanding of clinical governance, patient safety, and learning from adverse events evolved?
• How have these experiences impacted upon your current practice in identifying potential risks and contributing to a culture of safety and continuous improvement within the laboratory? Are you more proactive in suggesting changes to practice?
• How might these experiences contribute towards your future practice in leadership roles, contributing to clinical governance committees, or implementing significant changes in departmental procedures? What did you learn about root cause analysis and the importance of open communication?

Relevant learning outcomes

#	Outcome
# 1	Outcome Deliver quality patient centred care with the best interests of patients in all elements of practice.
# 2	Outcome Practice in accordance with local and national health and safety policies, regulatory requirements and overall service governance.
# 3	Outcome Communicate effectively with patients, relatives, healthcare professionals and other stakeholders.
# 9	Outcome Practice in partnership with other clinical specialisms as part of a multidisciplinary team and understand their roles and their impact on patient care and pathway.
# 10	Outcome Apply the principals of a quality management system to their professional practice.
# 11	Outcome Support innovation and development and participate in research, audits and service evaluations.
# 12	Outcome Assess and interpret patients’ needs to provide customised treatment dependent on medical, physical, social and psychological requirements.